Cardinal Capital Management Biogen Inc. Transaction History

Cardinal Capital Management

$631 Million
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$190.52 - $236.72 $5.8 Million - $7.21 Million	-30,467 Closed	0 $0
Q1 2024 Jul 12, 2024	BUY	$212.02 - $267.71 $603,196 - $761,634	2,845 Added 10.3%	30,467 $6.57 Million
Q1 2024 Apr 15, 2024	BUY	$212.02 - $267.71 $603,196 - $761,634	2,845 Added 10.3%	30,467 $6.57 Million
Q4 2023 Jul 12, 2024	SELL	$222.59 - $267.94 $1,780 - $2,143	-8 Reduced 0.03%	27,622 $7.15 Million
Q4 2023 Jan 26, 2024	SELL	$222.59 - $267.94 $1,780 - $2,143	-8 Reduced 0.03%	27,622 $7.15 Million
Q3 2023 Jul 12, 2024	BUY	$253.3 - $285.89 $91,441 - $103,206	361 Added 1.32%	27,630 $7.1 Million
Q3 2023 Oct 16, 2023	BUY	$253.3 - $285.89 $91,441 - $103,206	361 Added 1.32%	27,630 $7.1 Million
Q2 2023 Jul 12, 2024	SELL	$275.25 - $318.06 $880,249 - $1.02 Million	-3,198 Reduced 10.5%	27,269 $7.77 Million
Q2 2023 Jul 12, 2023	BUY	$275.25 - $318.06 $38,535 - $44,528	140 Added 0.52%	27,269 $7.77 Million
Q1 2023 Apr 18, 2023	SELL	$256.56 - $292.34 $29,247 - $33,326	-114 Reduced 0.42%	27,129 $7.54 Million
Q4 2022 Jan 20, 2023	BUY	$252.44 - $306.72 $771,204 - $937,029	3,055 Added 12.63%	27,243 $0
Q3 2022 Oct 21, 2022	SELL	$194.69 - $268.46 $613,273 - $845,648	-3,150 Reduced 11.52%	24,188 $6.46 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $16,878 - $20,071	90 Added 0.33%	27,338 $5.58 Million
Q1 2022 Apr 21, 2022	BUY	$193.77 - $244.14 $1.97 Million - $2.48 Million	10,172 Added 59.57%	27,248 $5.74 Million
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $94,046 - $120,863	-420 Reduced 2.4%	17,076 $4.1 Million
Q3 2021 Oct 21, 2021	SELL	$282.99 - $369.05 $16,696 - $21,773	-59 Reduced 0.34%	17,496 $4.95 Million
Q2 2021 Jul 14, 2021	BUY	$259.0 - $414.71 $49,987 - $80,039	193 Added 1.11%	17,555 $6.08 Million
Q1 2021 Apr 19, 2021	BUY	$242.95 - $284.63 $91,106 - $106,736	375 Added 2.21%	17,362 $4.86 Million
Q4 2020 Feb 01, 2021	BUY	$236.26 - $355.63 $57,883 - $87,129	245 Added 1.46%	16,987 $4.16 Million
Q3 2020 Oct 16, 2020	BUY	$264.77 - $305.71 $794 - $917	3 Added 0.02%	16,742 $4.75 Million
Q2 2020 Jul 16, 2020	SELL	$258.66 - $342.55 $7,501 - $9,933	-29 Reduced 0.17%	16,739 $4.48 Million
Q1 2020 Apr 20, 2020	BUY	$268.85 - $341.04 $10,216 - $12,959	38 Added 0.23%	16,768 $5.31 Million
Q4 2019 Jan 21, 2020	SELL	$220.06 - $304.07 $49,293 - $68,111	-224 Reduced 1.32%	16,730 $4.96 Million
Q3 2019 Oct 18, 2019	SELL	$217.44 - $243.88 $20,439 - $22,924	-94 Reduced 0.55%	16,954 $3.95 Million
Q2 2019 Jul 08, 2019	SELL	$219.29 - $241.72 $38,156 - $42,059	-174 Reduced 1.01%	17,048 $3.99 Million
Q1 2019 Apr 11, 2019	SELL	$216.71 - $338.96 $866 - $1,355	-4 Reduced 0.02%	17,222 $4.07 Million
Q4 2018 Jan 15, 2019	BUY	$278.5 - $352.75 $34,255 - $43,388	123 Added 0.72%	17,226 $5.18 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $28,763 - $37,615	-98 Reduced 0.57%	17,103 $6.04 Million
Q2 2018 Jul 25, 2018	BUY	$257.52 - $306.91 $4.43 Million - $5.28 Million	17,201 New	17,201 $4.99 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Account